TissueScan, Liver Cancer cDNA Array I

SKU
LVRT501
TissueScan Liver Cancer Tissue qPCR Panel I (10) containing ten identical sets of 48 tissues covering four disease stages and normal tissues
  $2,500.00
In Stock*
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Liver Cancer cDNA Array I
Clinical Info
Diagnosis Category Liver Cancer
Tissue Liver
Shipping Ambient
Description TissueScan Liver Cancer Tissue qPCR Panel I (10) containing ten identical sets of 48 tissues covering four disease stages and normal tissues
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

PTPRD is Homozygously Deleted and Epigenetically Downregulated in Human Hepatocellular Carcinomas
Acun, Demir, Oztas et al
OMICS (2015) 19 (4), 220-9 DOI: 10.1089/omi.2015.0010
Cited by 17
AI Summary: OriGene’s TissueScan Liver Cancer Tissue qPCR Panel I (Cat. No: LVRT501) was used to analyze PTPRD gene expression in human hepatocellular carcinoma and adjacent normal tissues, contributing to the study’s investigation of genetic and epigenetic alterations in HCC.
Snippet: 32 pairs of HCC and tumor-adjacent normal archival DNA samples had previously been described (Ozturk et al., 1991). TissueScan Liver Cancer Tissue qPCR Panel I (Cat. No: LVRT501) was purchased from Origene Technologies (Rockville, MD). ... Cite SaveSaving
The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine-rich glycoprotein
Deuschle, Birkel, Hambruch et al
Int. J. Cancer (2014)
Cited by 19
AI Summary: OriGene contributed to this study by providing a human liver cDNA panel (Cat# LVRT501), which was used to quantify HRG mRNA levels in normal liver, hepatocellular carcinoma (HCC), and non-malignant liver disease samples.
Snippet: mouse or human, respectively. HRG mRNA levels were quantified in human normal liver, HCC and non-malignant liver disease present on a cDNA panel purchased from Origene (Cat# LVRT501, Rockville). These cDNA samples ... Cite SaveSaving
FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model
Deuschle, Schüler, Schulz et al
PLoS ONE (2012) 7 (10), e43044 DOI: 10.1371/journal.pone.0043044
Cited by 83
AI Summary: In this paper, OriGene's human FXR expression plasmid (RC210844) and human NDRG2 expression plasmid (RC210368) were used to ectopically express these genes in hepatoma cell lines, enabling the authors to investigate the regulatory relationship between FXR and NDRG2 and their roles in liver cancer suppression.
Snippet: and 506 genes respectively). Genes containing such IR1 consensus sequences at comparable positions in all three species were considered good candidates for transcriptional control by FXR. Among those genes, NDRG2
FigureFigureFigure
Showing 1-3 of 3 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products